Inventor · disambiguated record
Ramesh Kashi
Also filed as: KASHI RAMESH · KASHI RAMESH S
16 granted patents·11 pending applications·290 citations·filing 2000–2024
94Inventor score
Top patents by PatentIndex Score
27 records- 0197US6586573B1Albumin-free Factor VIII formulationsBAXTER INT·Filed 2000·Granted Jul 1, 2003·129 cites·47 claims
- 0296US7247707B2Albumin-free factor VIII formulationsUNIV CONNECTICUT·Filed 2006·Granted Jul 24, 2007·38 cites·2 claims
- 0394US7087723B2Albumin-free factor VIII formulationsUNIV CONNECTICUT·Filed 2003·Granted Aug 8, 2006·48 cites·53 claims
- 0490US8372800B2Albumin-free factor VIII formulationsBAXTER INT·Filed 2011·Granted Feb 12, 2013·9 cites·39 claims
- 0589US8058226B2Albumin-free factor VIII formulationsBESMAN MARC·Filed 2007·Granted Nov 15, 2011·11 cites·47 claims
- 0688US11633476B2Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2018·Granted Apr 25, 2023·6 cites·21 claims
- 0787US9669076B2Albumin-free factor VIII formulationsBAXALTA INC·Filed 2016·Granted Jun 6, 2017·4 cites·13 claims
- 0884US8765665B2Albumin-free factor VIII formulationsBAXTER INT·Filed 2013·Granted Jul 1, 2014·4 cites·8 claims
- 0983US9803010B2Crystalline anti-human IL-23p19 antibodiesMERCK SHARP & DOHME·Filed 2013·Granted Oct 31, 2017·5 cites·8 claims
- 1083US9649383B2Liquid formulations for TNFR:Fc fusion proteinsMERCK SHARP & DOHME·Filed 2013·Granted May 16, 2017·7 cites·5 claims
- 1180US9352027B2Albumin-free factor VIII formulationsBAXTER INT·Filed 2014·Granted May 31, 2016·2 cites·10 claims
- 1279US8541002B2Vaccine for treatment and prevention of herpes simplex virus infectionTRUNEH ALEMSEGED·Filed 2004·Granted Sep 24, 2013·17 cites·43 claims
- 1379US2023263887A1Stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1479US2023321234A1Stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1577US7625584B2Method of complexing a protein by the use of a dispersed system and proteins thereofUNIV NEW YORK STATE RES FOUND·Filed 2004·Granted Dec 1, 2009·4 cites·16 claims
- 1675US2024239884A1SOLUTION FORMULATIONS OF ENGINEERED ANTI-IL-23p19 ANTIBODIESMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1769US2010105870A1Method Of Complexing A Protein By The Use Of A Dispersed System And Proteins ThereofBALASUBRAMANIAN SATHYAMANGALAM V·Filed 2009·Application pending·0 cites
- 1869US2022378916A1Compounds for reducing the viscosity of biological formulationsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1967US8263748B2Lyophilized formulations of engineered anti-IL-23p19 antibodiesLI XUHONG·Filed 2009·Granted Sep 11, 2012·5 cites·14 claims
- 2066US11014986B2Crystals of anti-human PD-1 monoclonal antibodiesREICHERT PAUL·Filed 2016·Granted May 25, 2021·1 cites·18 claims
- 2161US2021188964A1Solution Formulations of Engineered Anti-IL-23p19 AntibodiesMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 2260US12509509B2Solution formulations of engineered anti-IL-23p19 antibodiesMERCK SHARP & DOHME LLC·Filed 2013·Granted Dec 30, 2025·0 cites·6 claims
- 2360US2020206350A1Compounds for reducing the viscosity of biological formulationsMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
- 2454US2014105854A1Vaccine for treatment and prevention of herpes simplex virus infectionAGENUS INC·Filed 2013·Application pending·0 cites
- 2546US2002132982A1AHF associated dispersion system and method for preparationFiled 2001·Application pending·0 cites
- 2644US2017216428A1Vaccine for treatment and prevention of herpes simplex virus infectionAGENUS INC·Filed 2016·Application pending·0 cites
- 2742US2015307606A1Lyophilized spherical pellets of anti-il-23 antibodiesBASARKAR ASHWIN·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ramesh Kashi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →